1. Erlotinib has comparable clinical efficacy to chemotherapy in pretreated patients with advanced non-small cell lung cancer (NSCLC): A propensity-adjusted, outcomes research-based study. (October 2016) Authors: Neumair, P.; Joos, L.; Warschkow, R.; Dutly, A.; Ess, S.; Hitz, F.; Früh, M.; Brutsche, M.; Baty, F.; Krähenbühl, S.; Cerny, T.; Joerger, M. Journal: Lung cancer Issue: Volume 100(2016) Page Start: 38 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Erlotinib has comparable clinical efficacy to chemotherapy in pretreated patients with advanced non-small cell lung cancer (NSCLC): A propensity-adjusted, outcomes research-based study. (October 2016) Authors: Neumair, P.; Joos, L.; Warschkow, R.; Dutly, A.; Ess, S.; Hitz, F.; Früh, M.; Brutsche, M.; Baty, F.; Krähenbühl, S.; Cerny, T.; Joerger, M. Journal: Lung cancer Issue: Volume 100(2016) Page Start: 38 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Risk and patterns of secondary malignancies after primary breast cancer in women living in eastern Switzerland. (March 2017) Authors: Frick, H.; Thürlimann, B.; Rössle, M.; Ess, S.; Herrmann, C. Journal: Breast Issue: Volume 32(2017)Supplement 1 Page Start: S54 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Screening is associated with lower mastectomy rates in Switzerland. (March 2019) Authors: Herrmann, C.; Ess, S.; Walser, E.; Frick, H.; Thürlimann, B.; Probst-Hensch, N.; Rothermundt, C.; Mousavi, M.; Morant, R.; Vounatsou, P. Journal: Breast Issue: Volume 44(2019)Supplement 1 Page Start: S47 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗